- SMART Solutions by Alcon, a digital platform uniquely
designed for ophthalmology, builds on Alcon leadership in
image-guided clinic to OR connectivity through cloud-based planning
and surgical equipment
- Installs of first application, SMARTCataract, are underway
with U.S. customers; demos at AAO showcase connectivity of data
systems, diagnostic devices and surgical equipment to drive
efficiencies1-5
- Data on ORA SYSTEM, with a current database of more than 2
million cases, and ARGOS Biometer, will highlight benefits of
surgical accuracy and clinical efficiency
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated
to helping people see brilliantly, will feature its latest
advancement in integrated and connected surgical technologies –
SMART Solutions by Alcon, a digital platform uniquely designed for
ophthalmology – at the upcoming American Academy of Ophthalmology
(AAO) 2021 annual meeting. This new platform furthers Alcon’s
leadership in clinic-to-operating room (OR) integration with
image-guided technologies and cloud-based planning. Key data on
leading surgical equipment, ARGOS® Biometer with Image Guidance and
Optiwave Refractive Analysis (ORA) SYSTEM®, will also be presented
at the meeting.
SMARTCataract to be Showcased to U.S. Ophthalmologists at AAO
2021
Alcon will conduct live demos of SMARTCataract, the first
application under Alcon’s SMART Solutions platform. Key elements of
this novel application include planning, connectivity, analysis and
optimization – all designed to enable greater efficiency,
reliability and accuracy.1-5†
The application connects data systems and most diagnostic
devices, including ARGOS Biometer with Image Guidance, with Alcon’s
cataract surgical equipment, including LenSx® Femtosecond Laser and
LuxOR® Revalia™ Ophthalmic Microscope, as well as most commonly
used third-party microscopes – from the clinic to the OR and
back.
Alcon plans to roll out additional connectivity in the OR with
the ORA SYSTEM and NGENUITY® 3D Visualization System in the near
future.
“Alcon's SMARTCataract application can now give us tools that
tie together our biometry instruments and medical records with the
most modern IOL formulas, so state-of-the art surgical planning,
even for post-refractive patients, takes a fraction of the time it
used to. And, we can virtually eliminate manual data transfer from
one piece of equipment to the next, giving us peace of mind that
transcription errors are a thing of the past,” said Dr. John
Hovanesian, Harvard Eye Associates. “For my practice, this means
confidence in our surgical outcomes and a much better patient
experience."
SMART Solutions leverages the open, cloud-based infrastructure
and services of Philips HealthSuite, built on Amazon Web Services
(AWS), to enable surgeons to aggregate, organize and analyze all
relevant data within a single, integrated application designed for
security and remote planning.
“As the global leader in eye care, we are continuing to push the
boundaries of technology to help drive efficacy and accuracy with
cataract surgery,” said Sergio Duplan, President, North America,
Alcon. “We are collaborating with experts inside and outside of the
industry to build on our existing ecosystem and bring ongoing
advancements in this space.”
Alcon is expanding to additional customers in the U.S. through
the end of the year, with a broader rollout in 2022. For more
information about SMART Solutions and the SMARTCataract
application, please visit AlconSMARTSolutions.com.
Superior Refractive Outcomes Can Be Achieved Using ORA SYSTEM
Versus Barrett True K Formula6
ORA SYSTEM is the only intraoperative aberrometer on the market.
With the first and only database for real-time intraocular lens
(IOL) calculations during cataract surgery, the ORA SYSTEM
currently includes the power of more than two million cases.
A new, retrospective analysis on 1,067 eyes implanted with
AcrySof® IQ monofocal IOLs demonstrated that intraoperative
aberrometry achieved superior refractive outcomes (measured as
absolute prediction error p<0.005) in post-myopic LASIK/PRK eyes
versus using Barret True K alone.6 Constantly optimizing its
growing database of millions of cases, the ORA SYSTEM helps
surgeons to catch outliers in real-time before IOL implantation and
hit refractive targets with precision.7 An additional study on the
ORA SYSTEM will be presented:
- Comparison of Prediction Error Using Intraoperative Aberrometry
Guidance versus Preoperative Planning Following Trifocal IOL
Implantation, presented by Dr. John F. Blaylock (on demand
only).
ARGOS Achieves Superior Acquisition Rate, Outperforming
Lenstar* and IOLMaster* biometers; Demonstrates Time Savings for
Faster and Smarter Planning8-16
ARGOS is the industry-leading Swept Source Optical Coherence
Tomography (SS-OCT) biometer equipped with image guidance for a
faster and smarter planning solution. 9-12, 15
Data from the “Impact of an Optical Biometer’s Time Efficiency
in Cataract Evaluation and Surgery: A Time-and-Motion Study” will
highlight that ARGOS delivers substantial time efficiencies for
cataract surgery practices, surgeons and patients through its
superior acquisition rate and integration functionality.17 The
time-and-motion study being presented at AAO will demonstrate that
ARGOS can deliver efficiency gains in the evaluation of cataract
patients through measurement time and reducing the need for Manual
A-scan.8,10
The full abstract book, registration links for events taking
place onsite and booth information are all available at
MyAlconatAAO.com.
###
About SMART Solutions
SMART Solutions by Alcon is a comprehensive cloud-based digital
health solutions platform designed specifically for ophthalmology
practices. Through its SMARTCataract application, it enables
automatic evaluation of patient data and surgeon preferences to
make optimal recommendations that improve surgical accuracy and
lead to better patient outcomes for the treatment of cataracts.
Surgeons and their staff should refer to the equipment product
manuals for Important Product Information.
About ARGOS® Biometer with Image
Guidance
ARGOS is a non-invasive, non-contact biometer based on
sweptsource optical coherence tomography (SS-OCT). The device is
intended to acquire ocular measurements as well as perform
calculations to determine the appropriate intraocular lens (IOL)
power and type for implantation during intraocular lens placement.
Please refer to the ARGOS User Manual for a complete description of
proper use and maintenance, optical and technical specifications,
as well as a complete list of warnings and precautions.
About Optiwave Refractive Analysis
(ORA) SYSTEM®
The ORA SYSTEM technology utilizes wavefront aberrometry data to
measure and analyze the refractive power of the eye (i.e., sphere,
cylinder, and axis measurements) to support cataract surgical
procedures. Surgeons should refer to the ORA SYSTEM Operator’s
Manual for a complete description of proper use and maintenance, as
well as a complete list of warnings and cautions.
ABOUT ALCON
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases, and refractive errors. Our more than 23,000 associates
are enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
†Enabled with integrated Image Guidance by ALCON®.
*Trademarks are the property of their respective owners.
References
- Alcon Data on File, 2020.
- Blaylock JF, Hall B. Astigmatic results of a diffractive
trifocal toric IOL following intraoperative aberrometry guidance.
Clin Ophthalmol. 2020;14:4373-4378. doi: 10.2147/OPTH.S285711.
- Cionni RJ, Dimalanta R, Breen M, Hamilton C. A large
retrospective database analysis comparing outcomes of
intraoperative aberrometry with conventional preoperative planning.
J Cataract Refract Surg. 2018;44(10):1230-1235.
doi:10.1016/j.jcrs.2018.07.016
- Van Vliet EJ, Bredenhoff E, Sermeus W, Kop LM, Sol JCA, Harten
WH. Exploring the relation between process design and efficiency in
high-volume cataract pathways from a lean thinking perspective. Int
J Qual Health Care. 2011;23(1):83-93.
doi:10.1093/intqhc/mzq071.
- Håkansson I, Lundstr�m M, Stenevi U, Ehinger B. Data
reliability and structure in the Swedish National Cataract
Register. Acta Ophthalmol Scand. 2001;79(5):518-523.
doi:10.1034/j.1600-0420.2001.790519.x.
- Fram, Nicole R., MD. Refractive Prediction Accuracy Using
Intraoperative Aberrometry vs. Barrett True K in Post-Corneal
Refractive Surgery Eyes. AAO, New Orleans, LA. 12 November
2021.
- Alcon Data on File. 2021.
- Multack, Sam, DO, FAOCO. Impact of An Optical Biometer’s Time
Efficiency in Cataract Evaluation and Surgery: A Time-and-Motion
Study. AAO, New Orleans, LA. 12 November 2021.
- Tamaoki A, Kojima T, Hasegawa A, et al. Clinical Evaluation of
a New Swept-source Optical Coherence Biometer That Uses Individual
Refractive Indices to Measure Axial Length Cataract Patients.
Ophthalmic Res. 2019;19;1-13.
- Shammas HJ, Ortiz S, Shammas MC, et al. Biometry measurements
using a new large-coherence-length swept-source optical coherence
tomographer. J Cataract Refract Surg. 2016;42:50-61.
- Hussaindeen JR, Mariam EG, Arunachalam S, et al. Comparison of
Axial Length Using a New Swept-Source Optical Coherence
Tomography-Based Biometer. PLOS One. December 2018.
- Zeiss IOL Master 700 510k Submission 2015.
- ARGOS® Biometer User Manual. 2019.
- VERION® Reference Unit User Manual Part I. 2019.
- Whang, Woong-Joo. Predictive Accuracy of Partial Coherence
Interferometry and Swept-source Optical Coherence Tomography For
Intraocular Lens Power Calculation. Scientific Report. September
2018.
- Shammas HJ, Shammas MC, Jivrajka RV, Cooke DL, Potvin R.
Effects on IOL power calculation and expected clinical outcomes of
axial length measurements based on multiple vs single refractive
indices. Clin Ophthalmol. 2020;14:1511-1519.
- Woodard, Lawrence, MD. Time Efficiency of an Innovative Optical
Biometer in Cataract Surgery: A Time-and-Motion Study. ASCRS. Las
Vegas, NV. 23 July 2021.
Cautionary Note Regarding
Forward-Looking Statements
This press release contains
“forward-looking statements” within the meaning of the safe harbor
provisions of the United States Private Securities Litigation
Reform Act of 1995. Forward-looking statements can be identified by
words such as: “anticipate,” “intend,” “commitment,” “look
forward,” “maintain,” “plan,” “goal,” “seek,” “believe,” “project,”
“estimate,” “expect,” “strategy,” “future,” “likely,” “may,”
“should,” “will” and similar references to future periods.
Forward-looking statements are
neither historical facts nor assurances of future performance.
Instead, they are based only on our current beliefs, expectations
and assumptions regarding the future of our business, future plans
and strategies, and other future conditions. Because
forward-looking statements relate to the future, they are subject
to inherent uncertainties and risks that are difficult to predict.
Some of these factors are discussed in our filings with the United
States Securities and Exchange Commission, including our Form 20-F.
Should one or more of these uncertainties or risks materialize, or
should underlying assumptions prove incorrect, actual results may
vary materially from those anticipated. Therefore, you should not
rely on any of these forward-looking statements.
Forward-looking statements in this
press release speak only as of the date of its filing, and we
assume no obligation to update forward-looking statements as a
result of new information, future events or otherwise.
Connect with us on Facebook
LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211108005426/en/
Investor Relations Karen
King + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)
investor.relations@alcon.com
Media Relations Blake Overby
+ 1 817 551 4328 (Fort Worth) + 1 682 321 2897 (Fort Worth)
blake-1.overby@alcon.com
Alcon (NYSE:ALC)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Alcon (NYSE:ALC)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024